Hotchkis & Wiley Capital Management
BIIB icon

Hotchkis & Wiley Capital Management’s Biogen BIIB Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,800
Closed -$481K – 500
2022
Q3 		$481K Buy
1,800
+200
+13% +$42.5K ﹤0.01% 508
2022
Q2 		$326K Hold
1,600
– – ﹤0.01% 488
2022
Q1 		$337K Hold
1,600
– – ﹤0.01% 484
2021
Q4 		$384K Hold
1,600
– – ﹤0.01% 487
2021
Q3 		$453K Hold
1,600
– – ﹤0.01% 475
2021
Q2 		$554K Sell
1,600
-197,311
-99% -$59.8M ﹤0.01% 465
2021
Q1 		$55.6M Sell
198,911
-500
-0.3% -$135K 0.17% 87
2020
Q4 		$48.8M Sell
199,411
-4,900
-2% -$1.26M 0.17% 85
2020
Q3 		$58M Sell
204,311
-75,060
-27% -$20.9M 0.26% 70
2020
Q2 		$74.7M Sell
279,371
-100
-0% -$30.1K 0.35% 63
2020
Q1 		$88.4M Buy
279,471
+8,000
+3% +$2.43M 0.5% 53
2019
Q4 		$80.6M Buy
271,471
+33,399
+14% +$9.27M 0.28% 74
2019
Q3 		$55.4M Buy
238,072
+200
+0.1% +$46.6K 0.22% 85
2019
Q2 		$55.6M Sell
237,872
-2,500
-1% -$577K 0.21% 83
2019
Q1 		$56.8M Sell
240,372
-4,200
-2% -$1.32M 0.22% 88
2018
Q4 		$73.6M Sell
244,572
-8,600
-3% -$2.74M 0.32% 72
2018
Q3 		$89.4M Sell
253,172
-9,900
-4% -$3.41M 0.32% 73
2018
Q2 		$76.4M Sell
263,072
-4,600
-2% -$1.29M 0.29% 74
2018
Q1 		$73.3M Sell
267,672
-4,000
-1% -$1.24M 0.29% 73
2017
Q4 		$86.5M Sell
271,672
-3,100
-1% -$994K 0.33% 71
2017
Q3 		$86M Sell
274,772
-11,800
-4% -$3.49M 0.34% 70
2017
Q2 		$77.8M Hold
286,572
– – 0.31% 71
2017
Q1 		$78.4M Sell
286,572
-228
-0.1% -$64.5K 0.31% 72
2016
Q4 		$81.3M Sell
286,800
-19,300
-6% -$5.72M 0.33% 74
2016
Q3 		$95.8M Buy
306,100
+77,100
+34% +$22.8M 0.4% 64
2016
Q2 		$55.4M Buy
+229,000
New +$60.4M 0.24% 90

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management's BIIB Position: Q4 2022 in Review

Hotchkis & Wiley Capital Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 1,800 shares — an estimated $481K sold.

Hotchkis & Wiley Capital Management first reported a position in BIIB in Q2 2016 and held it in 26 quarters. The position peaked at $95.8M in Q3 2016. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Hotchkis & Wiley Capital Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 1,800 Biogen shares in Q4 2022, an estimated $481K.
  • Hotchkis & Wiley Capital Management first reported a position in Biogen in Q2 2016 and held it in 26 quarters.
  • Hotchkis & Wiley Capital Management's Biogen position peaked at $95.8M in Q3 2016.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.